Cintas Corporation
CTASLast close · Oct 16, 2026213.69+0.63 (+0.30%)
Market cap$84.9B
7 firms' latest targets, last 12 months: median $230.00 ($184.00–$250.00), 8% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-09-29 | Argus Research | $240.00 | — | +12% |
| 2026-09-24 | Baird | $222.00 | ▲ 4% | +4% |
| 2026-07-16 | UBS | $230.00 | ▲ 1% | +8% |
| 2026-07-16 | Wells Fargo | $250.00 | ▲ 2% | +17% |
| 2026-07-15 | Goldman Sachs | $231.00 | — | +8% |
| 2025-12-17 | Morgan Stanley | $210.00 | — | -2% |
| 2025-11-11 | Rothschild & Co Redburn | $184.00 | — | -14% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2024reported | $9.6B | +9% | $3.79 | +17% | est. $9.8B-2% | est. $4.03 | 11 |
| 2025reported | $10.3B | +8% | $4.40 | +16% | est. $10.3B+0% | est. $4.39 | 13 |
| 2026reported | $11.3B | +9% | $4.91 | +12% | est. $11.2B+0% | est. $4.90 | 16 |
| 2027 | $12.2B | +9% | $5.54 | +13% | $12.2B–$12.3B | $5.48–$5.59 | 15 |
| 2028 | $13.2B | +7% | $6.18 | +11% | $13.0B–$13.3B | $6.06–$6.28 | 15 |
| 2029 | $14.1B | +7% | $6.90 | +12% | $13.8B–$14.5B | $6.56–$7.08 | 10 |
| 2030 | $15.1B | +7% | $7.67 | +11% | $15.0B–$15.3B | $7.56–$7.77 | 5 |
| 2031 | $16.2B | +7% | $9.03 | +18% | $16.0B–$16.3B | $8.90–$9.15 | 4 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.